SCHEMBL7173871

SCHEMBL7173871

CN(C)C(=O)C(CCO)(c1ccccc1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 19/20 0.73
DRD3 P35462 15/20 0.73
DRD4 P21917 7/20 0.73
DRD2 P14416 14/20 0.60
MEN1 O00255 2/20 0.47
LMNA P02545 2/20 0.47
ADRB2 P07550 2/20 0.47
ADRA2A P08913 2/20 0.47
SLC6A4 P31645 2/20 0.47
OPRD1 P41143 2/20 0.47
OPRK1 P41145 2/20 0.47
HTR2B P41595 2/20 0.47
SLC6A3 Q01959 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
CES2 O00748 1/20 0.47
SLC22A1 O15245 1/20 0.47
USP2 O75604 1/20 0.47
ABCB11 O95342 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10440077 0.86 OPRM1 (0.73) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL20245629 0.84 OPRM1 (0.71) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL6016876 0.81 OPRM1 (0.67) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL12216191 0.81 OPRM1 (0.67) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL5038143 0.80 OPRM1 (0.65) OPRM1DRD3DRD4DRD2MEN1
Hydrochloric Acid SCHEMBL27553852 0.80 OPRM1 (0.65) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL6309263 0.80 OPRM1 (0.65) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL10884718 0.80 OPRM1 (0.65) OPRM1DRD3DRD4DRD2MEN1
SCHEMBL4399206 0.79 CYP1A2 (0.45) OPRM1DRD3DRD4DRD2LMNA
SCHEMBL9780534 0.78 OPRM1 (0.67) OPRM1DRD3DRD4DRD2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187206-A1 DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-09-09 WO disclosed
US-6573282-B1 Compositions for treatment of peripheral hyperalgesia are provided. The compositions contain an anti-hyperalgesia effective amount of one or more compounds that directly or indirectly interact with peripheral opiate receptors ADOLOR CORPORATION 2003-06-03 US disclosed
US-5994372-A ANTIDIARRHEA COMPOUND REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-11-30 US disclosed
EP-0852494-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-15 EP disclosed
WO-1997009973-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-03-20 WO disclosed